Navigation Links
Comments by the International Scientific Forum on Alcohol Research
Date:2/17/2012

s mostly applied to all conditions and should be applauded for consistency purposes, it has ignored seminal studies from outside that time frame that alter the quality of evidence grade and evidence statement.

6.Evidence quality grades of D and possibly C suggest that the evidence for those statements may be so unreliable that it would be better to make no evidence statement at all for those conditions.

7.We note that only health benefits and risks were considered. Alcohol is a complex subject and this review misses commentary on social benefits and risks.

8.Some of the evidence statements are too simplistic. They ignore the fact that some benefits or risks of alcohol may only become relevant at high alcohol use levels, that there is a balance between risk and benefit that for any condition has to be considered in the context of any individuals non alcohol based risk factors, and that in some conditions the benefit or risk is very small in absolute terms. Indeed, throughout the text there is no clear delineation between the effects of light-to-moderate and heavy alcohol consumption, especially regarding increased risks of adverse health effects the text refers throughout to "alcohol use or alcohol consumption", where amount and pattern are not considered.

9.A dual relationship exists between alcohol consumption and diabetes mellitus. Light to moderate drinking may be beneficial while heavy drinking is detrimental. (Baliunas et al., 2009 and cited in the World Health Organisation Global Status report on Alcohol and Health 2011). The grade of D for the evidence statement about alcohol and diabetes assigned in this review appears incorrect in light of these references and may reflect the fact that predominantly the review does not cover literature reported after 2009.

10.The authors appear to have assumed any cardioprotective effect of the alcohol component was due only to the reduction in the concentration of HDL cholesterol observed following
'/>"/>

Contact: R. Curtis Ellison
ellison@bu.edu
617-638-8080
Boston University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Director of Berman Institute comments on FDA Approval of first human embryonic stem cell trial
2. AMP submits comments on SACGHS report
3. AMP comments at FDA meeting on array-based tests
4. AMP comments at FDA meeting on next-generation sequencing
5. BIO-key(R) International To Exhibit at Oracle OpenWorld
6. Sentara begins international trial -- open at only 24 US locations
7. Perinatal Days and International Stillbirth Conference -- Nov.5-7
8. AVS 55th International Symposium & Exhibition, Oct. 19-24
9. Minnesota ecology professor wins international award for biodiversity and biofuels research
10. International Council for Science launches major research program on natural disasters
11. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
(Date:12/10/2014)... You,ve been here before: you desperately need to sign into ... key or the answer to your secret question. What,s your ... Today, Hoyos Labs , a digital infrastructure security ... an end to the frustration that comes with usernames, passwords ... a user,s smartphone to acquire his or her biometrics to ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... Microbes are everywhere thousands of species are in your mouth, ... in your mouth are mostly harmless as long as you ... gum disease a path into the blood stream. Microbes in ... country are also mostly harmless with some notable exceptions. ...
... from the National Cancer Centre Singapore, Duke-NUS Graduate Medical ... University (Thailand), have made a seminal breakthrough in understanding ... a rare but highly lethal form of liver cancer. ... Tan, Steve Rozen, Irinel Popescu and Vajaraphongsa Bhudhisawasdi, used ...
... the first conference of its 2013-2014 meeting season and ... "Advancing Vaccines in the Genomics Era" at the Windsor ... Grand Challenges in Global Health meeting for that program,s ... Symposia Global Health Series, supported by the Bill & ...
Cached Biology News:Virginia Tech researchers explore natural way to displace harmful germs from household plumbing 2Virginia Tech researchers explore natural way to displace harmful germs from household plumbing 3Virginia Tech researchers explore natural way to displace harmful germs from household plumbing 4Singapore scientists expose molecular secrets of bile duct cancers from different countries 2Singapore scientists expose molecular secrets of bile duct cancers from different countries 3Keystone Symposia launches 2013-14 meeting series with first conference in Rio de Janeiro 2
(Date:12/22/2014)... Malvern, PA & Brussels (PRWEB) December 22, 2014 ... Education (CfPIE), the global leader of technical training ... Society for Clinical Data Management (SCDM) to ... training and certification programs —providing access to the ... The partnership extends SCDM members with 10% off when ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... and editorials addressing developments and pathways related to ... provocative article exploring the role of follicle-stimulating hormone ... of prostate cancer. , The article references ... that there could be a connection to prostate ...
(Date:12/19/2014)... Tigard, OR and Hershey, PA (PRWEB) December 19, ... (OTC Pink: BJCT), a leading developer and manufacturer ... has entered into an agreement with Immunomic Therapeutics, ... Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ ... receives an option for an exclusive Worldwide license ...
Breaking Biology Technology:CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... 13, 2011 PrimeraDx today announced that Jeff Liter ... Development.   "Jeff,s diverse background in all ... to the leadership team," Said Matt McManus, President and ... capabilities of the ICE Plex system in the ...
... a human gene mutation in a patient,s stem cells. ... 12 October, brings the possibility of patient-specific therapies closer ... researchers from the Wellcome Trust Sanger Institute and the ... both cirrhotic liver disease and lung emphysema. Using cutting-edge ...
... Life Technologies Corporation (NASDAQ: LIFE ) ... Sequencing 200 Kit, which enables 200 base pair reads. The ... sequencer that can deliver millions of highly accurate long reads ... after our launch, the speed, simplicity and scalability of ...
Cached Biology Technology:PrimeraDx Appoints Jeff Liter as VP of Corporate Development 2Clean correction of a patient's genetic mutation 2Clean correction of a patient's genetic mutation 3Ion Torrent Gets Better Faster With 4th Qtr New Product Releases 2Ion Torrent Gets Better Faster With 4th Qtr New Product Releases 3Ion Torrent Gets Better Faster With 4th Qtr New Product Releases 4Ion Torrent Gets Better Faster With 4th Qtr New Product Releases 5
... These plastic feeding tubes for rodent ... reduce the risk of perforation and trauma. ... hassle of cleaning and the risk of ... 20ga ...
Barcoded Slides, 5 Packs of 5 Slides (25/Case)...
...
... the 9, 10, 12, and 13 positions. It ... for the quantification of 13(S)-HODE by GC- or ... linoleic acid with plant and mammalian lipoxygenases. It ... tumor cells to the endothelium at concentrations around ...
Biology Products: